Model for gene-environment interaction: The case for dialysis

Seminars in Dialysis

Volumn 18, Issue 1, 2005, Pages 41-46

  Liangos, Orfeas ^a   Balakrishnan, Vaidyanathapuram S ^a   Jaber, Bertrand L ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); INTERLEUKIN 10; INTERLEUKIN 6; MYELOPEROXIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ANEMIA; BONE DISEASE; CARDIOVASCULAR DISEASE; DIALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; ENVIRONMENTAL FACTOR; GENE; GENE INTERACTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEMODIALYSIS PATIENT; HUMAN; INFECTION; INFLAMMATION; INTERLEUKIN 10 GENE; INTERLEUKIN 6 GENE; KIDNEY FAILURE; MALNUTRITION; MEDICAL RESEARCH; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; MODEL; MYELOPEROXIDASE GENE; PLASMINOGEN ACTIVATOR INHIBITOR 1 GENE; POPULATION RESEARCH; PREVALENCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SCIENCE; TRANSFORMING GROWTH FACTOR BETA1 GENE; TUMOR NECROSIS FACTOR ALPHA GENE;

CYTOKINES; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY FAILURE, CHRONIC; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PEROXIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; PROTEINS; RENAL DIALYSIS; RENIN-ANGIOTENSIN SYSTEM;

EID: 14844304022     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2005.18103.x     Document Type: Review

References (34)

1. Osono E, Kurihara S, Hayama N, Sakurai Y, Ohwada K, Onoda N, Takeuchi M, Tomizawa T, Komaba Y, Hashimoto K, Matsunobu S, Yoneshima H, Iino Y: Insertion/deletion polymorphism in intron 16 of the ACE gene and left ventricular hypertrophy in patients with end-stage renal disease. Am J Kidney Dis. 32:725-730, 1998
2. Nergizoglu G, Keven K, Gurses MA, Aras O, Erturk S, Duman N, Ates K, Akar H, Akar N, Karatan O, Erbay B, Ertug AE: Carotid intima-media thickness and ACE-gene polymorphism in hemodialysis patients. J Nephrol 12:261-265, 1999
3. Varagunam M, McCloskey DJ, Sinnott PJ, Raftery MJ, Yaqoob MM: Angiotensin-converting enzyme gene polymorphism and erythropoietin requirement. Perit Dial Int 23:111-115, 2003
4. Wang AY, Chan JC, Wang M, Poon E, Lui SF, Li PK, Sanderson J: Cardiac hypertrophy and remodeling in relation to ACE and angiotensinogen genes genotypes in Chinese dialysis patients. Kidney Int 63:1899-1907, 2003
5. Losito A, Kalidas K, Santoni S, Jeffery S: Association of interleukin-6-174G/C promoter polymorphism with hypertension and left ventricular hypertrophy in dialysis patients. Kidney Int 64:616-622, 2003
6. Balakrishnan VS, Guo D, Rao M, Jaber BL, Tighiouart H, Freeman RL, Huang C, King AJ, Pereira BJ: Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin. Kidney Int 65:1449-1460, 2004
7. Ram S, Bass K, Abreo K, Baier RJ, Kruger TE: Tumor necrosis factor-alpha -308 gene polymorphism is associated with synthetic hemodialysis graft failure. J Invest Med 51:19-26, 2003
8. Girndt M, Kaul H, Sester U, Ulrich C, Sester M, Georg T, Kohler H: Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int 62:949-955, 2002
9. Girndt M, Sester U, Sester M, Deman E, Ulrich C, Kaul H, Kohler H: The interleukin-10 promoter genotype determines clinical immune function in hemodialysis patients. Kidney Int 60:2385-2391, 2001
10. Aucella F, Margaglione M, Vigilante M, Gatta G, Grandone E, Forcella M, Ktena M, De Min A, Salatino G, Procaccini DA, Stallone C: PAI-1 4G/5G and ACE I/D gene polymorphisms and the occurrence of myocardial infarction in patients on intermittent dialysis. Nephrol Dial Transplant 18:1142-1146, 2003
11. Rao M, Guo D, Jaber BL, Tighiouart H, Pereira BJ, Balakrishnan VS: Transforming growth factor-beta 1 gene polymorphisms and cardiovascular disease in hemodialysis patients. Kidney Int 66:419-427, 2004
12. Heine GH, Ulrich C, Sester U, Sester M, Kohler H, Girndt M: Transforming growth factor beta1 genotype polymorphisms determine AV fistula patency in hemodialysis patients. Kidney Int 64:1101-1107, 2003
13. Pecoits-Filho R, Stenvinkel P, Marchlewska A, Heimburger O, Barany P, Hoff CM, Holmes CJ, Suliman M, Lindholm B, Schalling M, Nordfors L: A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients. Kidney Int Suppl 84:S172-S176, 2003
14. Fukasawa M, Matsushita K, Kamiyama M, Mikami Y, Araki I, Yamagata Z, Takeda M: The methylenetetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients. Am J Kidney Dis 41:637-642, 2003
15. Lim PS, Hung WR, Wei YH: Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis. Nephron 87:249-256, 2001
16. Fodinger M, Mannhalter C, Wolfl G, Pabinger I, Muller E, Schmid R, Horl WH, Sunder-Plassmann G: Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients. Kidney Int 52:517-523, 1997
17. Haviv YS, Shpichinetsky V, Goldschmidt N, Atta IA, Ben-Yehuda A, Friedman G: The common mutations C677T and A1298C in the human methylenetetrahydrofolate reductase gene are associated with hyperhomocysteinemia and cardiovascular disease in hemodialysis patients. Nephron 92:120-126, 2002
18. Imura T, Kimura H, Gejyo F: Apolipoprotein E phenotypes in hemodialysis patients. Kidney Int Suppl 71:S245-S247, 1999
19. Eggertsen G, Heimburger O, Stenvinkel P, Berglund L: Influence of variation at the apolipoprotein E locus on lipid and lipoprotein levels in CAPD patients. Nephrol Dial Transplant 12:141-144, 1997
20. Feussner G, Wey S, Bommer J, Deppermann D, Grutzmacher P, Ziegler R: Apolipoprotein E phenotypes and hyperlipidemia in patients under maintenance hemodialysis. Hum Genet 88:307-312, 1992
21. Choi GR, Suh SP, Song JW, Kee SJ, Shin JH, Ryang DW: Genetic variation of the Apo AI-CIII-AIV gene cluster in hypertriglyceridemic patients with chronic renal failure undergoing hemodialysis. J Korean Med Sci 15:289-294, 2000
22. Asanuma K, Yokoyama K, Tsukada T, Takemoto F, Hara S, Yamada A, Tomino Y: An intron 4 gene polymorphism in endothelial cell nitric oxide synthase might modulate lipid metabolism in nondiabetic patients on hemodialysis. Nephron 88:39-43, 2001
23. Yokoyama K, Tsukada T, Nakayama M, Hara S, Yamada A, Kawaguchi Y, Hosoya T: An intron 4 gene polymorphism in endothelial cell nitric oxide synthase might modulate volume-dependent hypertension in patients on hemodialysis. Nephron 85:232-237, 2000
24. Stachowski J, Kramer J, Fust G, Maciejewski J, Baldamus CA, Petranyi GG: Relationship between the reactivity to hepatitis B virus vaccination and the frequency of MHC class I, II and III alleles in haemodialysis patients. Scand J Immunol 42:60-65, 1995
25. Dincer D, Besisik F, Oguz F, Sever MS, Kaymakoglu S, Cakaloglu Y, Demir K, Turkoglu S, Carin M, Okten A: Genes of major histocompatibility complex class II influence chronic C hepatitis treatment with interferon in hemodialysis patients. Int J Artif Organs 24:212-214, 2001
26. Kramer J, Stachowski J, Barth C, Ujhelyi E, Tarjan V, Sulowicz W, Fust G, Baldamus CA: Genetic regulation of the impaired immune response to hepatitis-B vaccine associated with low TCR density in end stage renal disease patients: contribution of complement C4 and factor B alleles. Immunol Lett 59:13-19, 1997
27. Omori K, Kazama JJ, Song J, Goto S, Takada T, Saito N, Sakatsume M, Narita I, Gejyo F: Association of the MCP-1 gene polymorphism A-2518G with carpal-tunnel syndrome in hemodialysis patients. Amyloid 9:175-182, 2002
28. Taccone-Gallucci M, Di Nucci G, Meloni C, Mariani G, Valeri M, Piazza A, Elia L, Torromeo C, Mandelli F, Casciani CU: Risk of iron overload and "hemochromatosis allele(s)" in patients on maintenance hemodialysis. Am J Nephrol 7:28-32, 1987
29. Canavese C, Bergamo D, Barbieri S, Timbaldi M, Thea A, Martina G, Damiani D, Fenoglio R, Donati-Marella B, Priolo G: Clinical relevance of hemochromatosis-related HFE C282Y/H63D gene mutations in patients on chronic dialysis. Clin Nephrol 58:438-444, 2002
30. Erturk S, Kutlay S, Karabulut HG, Keven K, Nergizoglu G, Ates K, Bokesoy I, Duman N: The impact of vitamin D receptor genotype on the management of anemia in hemodialysis patients. Am J Kidney Dis 40:816-823, 2002
31. Marco MP, Craver L, Betriu A, Fibla J, Fernandez E: Influence of vitamin D receptor gene polymorphisms on mortality risk in hemodialysis patients. Am J Kidney Dis 38:965-974, 2001
32. Nagaba Y, Heishi M, Tazawa H, Tsukamoto Y, Kobayashi Y: Vitamin D receptor gene polymorphisms affect secondary hyperparathyroidism in hemodialyzed patients. Am J Kidney Dis 32:464-469, 1998
33. Yokoyama K, Shigematsu T, Kagami S, Tsukada T, Arai T, Hara S, Yamada A, Kawaguchi Y, Hosoya T: Vitamin D receptor gene polymorphism detected by digestion with Apa I influences the parathyroid response to extracellular calcium in Japanese chronic dialysis patients. Nephron 89:315-320, 2001
34. Yano S, Sugimoto T, Kanzawa M, Tsukamoto T, Hattori T, Hattori S, Chihara K: Association of polymorphic alleles of the calcium-sensing receptor gene with parathyroid hormone secretion in hemodialysis patients. Nephron 85:317-323, 2000